Navigation Links
Surefire Infusion System Used In Potential New Hunger-Reducing Obesity Treatment -- NIH Funds Johns Hopkins Study

WESTMINSTER, Colo., May 2, 2013 /PRNewswire/ -- Surefire Medical, Inc., the developer of a new class of infusion systems designed to maximize targeted delivery of embolization agents without reflux, today announced that the company's Surefire Infusion System will be used in the development of the first clinically viable microcatheter-based, minimally invasive treatment for obesity as an alternative to bariatric surgery.

The Bariatric Arterial Embolization research at Johns Hopkins Medicine, led by principal investigators, Clifford Weiss , M.D., Assistant Professor of Radiology, and Dara Kraitchman , V.M.D, Ph. D,. FACC, Professor of Radiology, a porcine study, began May 1, 2013 with a $1.3 million grant from the National Institutes of Health (NIH). 

The procedure precisely targets the fundus, the area of the stomach that produces ghrelin or the 'hunger hormone.'   Multiple pharmacological attempts to curb ghrelin, a gastric hormone that stimulates hunger, have been largely unsuccessful. 

The novel Surefire Infusion technology, with its unique expandable antireflux tip, was chosen for its ability to:

  • Improve targeting
  • Prevent reflux into healthy, non-target tissue
  • Achieve deeper penetration of the X-Ray visible embolic beads (XEBs) developed for this study

"Bariatric Embolization will be the world's first image-guided, minimally invasive procedure targeting obesity that could be a viable alternative to bariatric surgery," said Aravind Arepally , M.D., Surefire Medical's Chief Scientific Officer and former Clinical Director for the Center for Bioengineering Innovation and Design at Johns Hopkins.  "In our prior work, which showed that this procedure may be as effective as bariatric surgery in curbing hunger, we realized that precise delivery into the gastric fundus was critical.   The Surefire's unique properties enable the more highly targeted, precise delivery vital for development of a new obesity treatment."

About Surefire Medical
Surefire Medical, Inc., based in Westminster, Colo., was founded in 2009 to develop innovative infusion systems for the interventional radiology and interventional oncology markets.  Surefire's infusion systems are designed to precisely deliver embolic agents through a unique microcatheter with an expandable tip that collapses in forward flow and dynamically expands to the vessel wall in reverse flow in order to maximize targeted delivery, minimize reflux and reduce damage to healthy tissue.  For more information, please visit

SOURCE Surefire Medical, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Surefire Medical Receives FDA Clearance For High-Flow Microcatheter
2. Surefire Medicals Infusion System For Embolization Procedures Receives CE Mark Approval
3. Christopher Mennone Joins Surefire Medical Team As International Business Director
4. Surefire Medical, Inc.: Gene McGrevin Joins Surefire Medicals Board of Directors
5. Study: Surefire Medicals Technology Improves Delivery Of Embolics In Cancer Treatment
6. Aperture Health, Inc. focuses in on IV Therapy Value Creation and the Merger and Acquisition Activities in the Home Infusion Therapy Sector.
7. CareFusion Expands Infusion Pump Interoperability
8. Global Infusion Pumps Market 2011-2015
9. Riordan Lewis & Haden
10. Equity Partners Acquires Nutritional Therapy Provider DCRX Infusion
11. Hospira and Q Core Medical Sign International Distribution Agreement for Sapphire Infusion System
Post Your Comments:
(Date:11/25/2015)... 25, 2015 Allergan plc (NYSE: ... Rugen Therapeutics, a start-up  biotechnology company focused on ... disorders and funded by the F-Prime Biomedical Research ... into an exclusive collaboration to support the discovery ... Disorders (ASD) and Obsessive Compulsive disorders (OCD). ...
(Date:11/25/2015)... 2015 USP 800 applies to all ... pharmacists, pharmacy technicians, nurses, physicians, physician assistants, home ... also covers all entities which store, prepare, transport, ... healthcare institutions, patient treatment clinics, physicians, practice facilities, ... --> What is the purpose of ...
(Date:11/25/2015)... 2015 Asia -based ... BioLight and the New Investors will make a direct ... a private placement. The financing will help IOPtima to ... used in the treatment of glaucoma, as well as ... IOPtimate™ system with the U.S. Food and Drug Administration, ...
Breaking Medicine Technology:
(Date:11/26/2015)... ... ... The Catalent Applied Drug Delivery Institute today announced a ... selection in early phase drug development. The first of these is to be ... UK’s emerging life sciences companies, corporate partners, and investors, at Milton Park, Oxford, ...
(Date:11/26/2015)... , ... November 26, 2015 , ... ... medical opinion process, participated in the 61st annual Employee Benefits Conference. The Employee ... took place Sunday, November 8th through Wednesday, November 11th, 2015. The conference was ...
(Date:11/26/2015)... ... November 26, 2015 , ... Indosoft Inc., developer and ... an application server to improve system efficiency and reliability. , The new Q-Suite 6 ... these standards, the system avoids locking itself into a specific piece of software for ...
(Date:11/25/2015)... ... , ... The holiday season is jam-packed with family dinners, ... attendees is of the utmost importance. Whether you are cooking at home for ... a try this holiday season. , Turkey Croquettes ,     Ingredients: , ...
(Date:11/25/2015)... ... 2015 , ... TyloHelo Inc , North America’s largest ... accessories help improve the bather experience in the sauna, and the accessories selected ... purist looking for simplicity in design to accessories that encourage a greater expression ...
Breaking Medicine News(10 mins):